Literature DB >> 12089340

Interaction of intracellular beta amyloid peptide with chaperone proteins.

Virginia Fonte1, Wadim Jan Kapulkin, Vadim Kapulkin, Andrew Taft, Amy Fluet, David Friedman, Christopher D Link.   

Abstract

Expression of the human beta amyloid peptide (A beta) in transgenic Caenorhabditis elegans animals can lead to the formation of intracellular immunoreactive deposits as well as the formation of intracellular amyloid. We have used this model to identify proteins that interact with intracellular A beta in vivo. Mass spectrometry analysis of proteins that specifically coimmunoprecipitate with A beta has identified six likely chaperone proteins: two members of the HSP70 family, three alpha B-crystallin-related small heat shock proteins (HSP-16s), and a putative ortholog of a mammalian small glutamine-rich tetratricopeptide repeat-containing protein proposed to regulate HSP70 function. Quantitative reverse transcription-PCR analysis shows that the small heat shock proteins are also transcriptionally induced by A beta expression. Immunohistochemistry demonstrates that HSP-16 protein closely colocalizes with intracellular A beta in this model. Transgenic animals expressing a nonaggregating A beta variant, a single-chain A beta dimer, show an altered pattern of coimmunoprecipitating proteins and an altered cellular distribution of HSP-16. Double-stranded RNA inhibition of R05F9.10, the putative C. elegans ortholog of the human small glutamine-rich tetratricopeptide-repeat-containing protein (SGT), results in suppression of toxicity associated with A beta expression. These results suggest that chaperone function can play a role in modulating intracellular A beta metabolism and toxicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089340      PMCID: PMC123159          DOI: 10.1073/pnas.152313999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors:  S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

3.  Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines.

Authors:  Xiaoyan Sun; Gregory M Cole; Teresa Chu; Weiming Xia; Douglas Galasko; Haruyasu Yamaguchi; Kentaro Tanemura; Sally A Frautschy; Akihiko Takashima
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

Review 4.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

5.  Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells.

Authors:  Hoau Yan Wang; Michael R D'Andrea; Robert G Nagele
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

6.  Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice.

Authors:  G P Lim; F Yang; T Chu; E Gahtan; O Ubeda; W Beech; J B Overmier; K Hsiao-Ashec; S A Frautschy; G M Cole
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

7.  Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.

Authors:  Pavan K Auluck; H Y Edwin Chan; John Q Trojanowski; Virginia M Y Lee; Nancy M Bonini
Journal:  Science       Date:  2001-12-20       Impact factor: 47.728

8.  Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease.

Authors:  M R D'Andrea; R G Nagele; H Y Wang; P A Peterson; D H Lee
Journal:  Histopathology       Date:  2001-02       Impact factor: 5.087

9.  Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans.

Authors:  L Timmons; D L Court; A Fire
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

10.  Structure, expression, and evolution of a heat shock gene locus in Caenorhabditis elegans that is flanked by repetitive elements.

Authors:  D Jones; R H Russnak; R J Kay; E P Candido
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

View more
  64 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.

Authors:  Edward F Griffin; Xiaohui Yan; Kim A Caldwell; Guy A Caldwell
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

3.  A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease.

Authors:  Barbara A Cottrell; Veronica Galvan; Surita Banwait; Olivia Gorostiza; Christian R Lombardo; Tristan Williams; Birgit Schilling; Alyson Peel; Bradford Gibson; Edward H Koo; Christopher D Link; Dale E Bredesen
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

Review 4.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

Review 5.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 6.  Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.

Authors:  Sandeep K Sharma; Smriti Priya
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

7.  Small glutamine-rich tetratricopeptide repeat-containing protein (SGT) interacts with the ubiquitin-dependent endocytosis (UbE) motif of the growth hormone receptor.

Authors:  Julia A Schantl; Marcel Roza; Ad P De Jong; Ger J Strous
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 8.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

9.  The co-chaperone SGT of Leishmania donovani is essential for the parasite's viability.

Authors:  Gabi Ommen; Mareike Chrobak; Joachim Clos
Journal:  Cell Stress Chaperones       Date:  2009-12-02       Impact factor: 3.667

Review 10.  Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.

Authors:  Gary A Silverman; Cliff J Luke; Sangeeta R Bhatia; Olivia S Long; Anne C Vetica; David H Perlmutter; Stephen C Pak
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.